- Home
- TTI vs EYPT Comparison
TTI vs EYPT Comparison
Compare TTI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTI
- EYPT
- Stock Information
- Founded
- TTI 1981
- EYPT 1987
- Country
- TTI United States
- EYPT United States
- Employees
- TTI N/A
- EYPT N/A
- Industry
- TTI Oil & Gas Production
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- TTI Energy
- EYPT Industrials
- Exchange
- TTI Nasdaq
- EYPT Nasdaq
- Market Cap
- TTI 467.4M
- EYPT 427.9M
- IPO Year
- TTI 1990
- EYPT 2005
- Fundamental
- Price
- TTI $2.50
- EYPT $5.68
- Analyst Decision
- TTI Strong Buy
- EYPT Strong Buy
- Analyst Count
- TTI 3
- EYPT 8
- Target Price
- TTI $6.67
- EYPT $25.71
- AVG Volume (30 Days)
- TTI 1.5M
- EYPT 907.9K
- Earning Date
- TTI 04-29-2025
- EYPT 05-07-2025
- Dividend Yield
- TTI N/A
- EYPT N/A
- EPS Growth
- TTI 311.87
- EYPT N/A
- EPS
- TTI 0.82
- EYPT N/A
- Revenue
- TTI $599,111,000.00
- EYPT $43,273,000.00
- Revenue This Year
- TTI $8.58
- EYPT N/A
- Revenue Next Year
- TTI $10.67
- EYPT N/A
- P/E Ratio
- TTI $2.91
- EYPT N/A
- Revenue Growth
- TTI N/A
- EYPT N/A
- 52 Week Low
- TTI $2.03
- EYPT $3.91
- 52 Week High
- TTI $5.12
- EYPT $22.13
- Technical
- Relative Strength Index (RSI)
- TTI 36.59
- EYPT 50.79
- Support Level
- TTI $2.24
- EYPT $3.91
- Resistance Level
- TTI $2.44
- EYPT $5.86
- Average True Range (ATR)
- TTI 0.25
- EYPT 0.54
- MACD
- TTI -0.02
- EYPT 0.13
- Stochastic Oscillator
- TTI 30.13
- EYPT 90.77
About TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.